Oruka Therapeutics, Inc. (NASDAQ:ORKA) institutional investors have had a good week as stock gains 15%
Key Insights Institutions' substantial holdings in Oruka Therapeutics implies that they have significant influence ...
Oruka Therapeutics (ORKA) Gets a Buy from TD Cowen
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) today. The company’s shares closed ...
Gistmania4d
South Africa Ranks Last In The World in Mathematics and Science
Trends in International Mathematics and Science Study (TIMSS) revealed a concerning performance by South African students, ...
Gistmania4d
UK Court Reverses Ruling, Orders Deportation of 43yr Old Nigerian, Olutobi Ogunbanwo
A United Kingdom upper tribunal has reversed a previous ruling that stopped the deportation of 43-year-old Nigerian Olutobi ...
Promising Potential of Oruka Therapeutics’ ORKA-001 in Psoriasis Treatment
Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) and keeping the price target at ...